Myelin Repair Foundation Research Fosters a Clinical Trial for Multiple Sclerosis

Published: Mar 07, 2012

SARATOGA, Calif.--(BUSINESS WIRE)--The Myelin Repair Foundation (MRF) announced today that its research might soon lead into a clinical proof-of-concept trial at the Department of Neuroimmunology and Multiple Sclerosis Research (nims), University Hospital Z├╝rich, Switzerland, and the Institute for Neuroimmunology and Clinical Multiple Sclerosis Research (inims) in Hamburg, Germany. This clinical trial will determine the safety and efficacy of a potential therapeutic pathway to desensitize the immune system to myelin in multiple sclerosis (MS) patients, based on research conducted by MRF Investigator Dr. Stephen D. Miller from Northwestern University Feinberg School of Medicine.

Back to news